Drug Trial Radar · NCT02998840
A Prospective Study of B244 Delivered as a Topical Spray to Determine Safety and Efficacy in Subjects With Elevated Blood Pressure
Last checked: Nov 19, 2026Latest source record: Sep 15, 2022 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
132
Actual
Start
Nov 2016
Primary completion
Apr 25, 2017
Study completion Jun 26, 2017
Sponsor
- Lead sponsor
- AOBiome LLCIndustry
- Sponsor type
- Industry
- Collaborators
- Veristat, Inc.
- First posted
- Dec 21, 2016
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate and compare the efficacy of B244 in treating patients with hypertension.
Conditions
- Prehypertension
- Hypertension, Stage I
Interventions
B244Biological
odorless suspension
VehicleBiological
odorless suspension
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With Treatment-related Adverse Events as Assessed by CTCAE v4.0Time frame: Baseline-6 weeks
- Difference in Mean in Clinic Systolic BP Between the Active and Vehicle GroupsTime frame: Baseline-Week 4
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Central Research Associates
Birmingham, Alabama
Elite Clinical Studies
Phoenix, Arizona
Orange County Research Center
Tustin, California
Clinical Research Consulting
Milford, Connecticut
AGA Clinical Trials
Hialeah, Florida
ICCT Research International
Chicago, Illinois
MedPharmics
Metairie, Louisiana
Alternative Primary Care (Einstein Clinical Research)
Silver Spring, Maryland
CHEAR Center
The Bronx, New York
Research Trials WorldWide
Humble, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.